SOCS3 deletion promotes optic nerve regeneration in vivo - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec 10;64(5):617-23.
doi: 10.1016/j.neuron.2009.11.021.

SOCS3 deletion promotes optic nerve regeneration in vivo

Affiliations

SOCS3 deletion promotes optic nerve regeneration in vivo

Patrice D Smith et al. Neuron. .

Abstract

Axon regeneration failure accounts for permanent functional deficits following CNS injury in adult mammals. However, the underlying mechanisms remain elusive. In analyzing axon regeneration in different mutant mouse lines, we discovered that deletion of suppressor of cytokine signaling 3 (SOCS3) in adult retinal ganglion cells (RGCs) promotes robust regeneration of injured optic nerve axons. This regeneration-promoting effect is efficiently blocked in SOCS3-gp130 double-knockout mice, suggesting that SOCS3 deletion promotes axon regeneration via a gp130-dependent pathway. Consistently, a transient upregulation of ciliary neurotrophic factor (CNTF) was observed within the retina following optic nerve injury. Intravitreal application of CNTF further enhances axon regeneration from SOCS3-deleted RGCs. Together, our results suggest that compromised responsiveness to injury-induced growth factors in mature neurons contributes significantly to regeneration failure. Thus, developing strategies to modulate negative signaling regulators may be an efficient strategy of promoting axon regeneration after CNS injury.

PubMed Disclaimer

Figures

Figure 1
Figure 1. SOCS3 deletion promotes RGC axon regeneration
(A–E) Confocal images of optic nerves showing CTB-labeled axons around the lesion sites at 14 days (A and B), 1 day (C), 3 day (D), 7 days (E) post crush injury (dpc) from SOCS3f/f mice injected with AAV-GFP (A) or AAV-Cre (B–E). *: crush site. Scale bar: 100 µm. (F) Quantification of regenerating axons at different distances distal to the lesion sites at 14 days after crush injury. At least 5 different sections (every 4th section) from each animal were quantified. At 14 dpc, there were significant differences between control and SOCS3-deleted mice groups (ANOVA with Bonferroni’s post-test, p < 0.05 for each distance, 8 animals in each group). (G) Fluorescent photomicrographs of retinal whole-mounts showing surviving TUJ1+ RGCs at 14 days after injury. Scale bar: 50 µm. (H) Quantification of RGC survival at 14 dpc, expressed as a percentage of the total number of TUJ1+ RGCs in the contralateral (intact) retina. (n = 8 for each group). For each retina, 15–20 fields were chosen from different parts of the retina. The total viable RGC number was obtained by multiplying the average number per field of TUJ1+ cells in the ganglion cell layer by the retinal area. *: p < 0.01, Dunnett’s test.
Figure 2
Figure 2. Phospho-S6 levels in RGCs of SOCS3f/f mice with AAV-GFP or AAV-Cre after optic nerve injury
(A, B) Immunofluorescence analysis with anti-p-S6 or TUJ-1 antibodies of the retinal sections from SOCS3f/f mice injected with AAV-GFP (A) or AAV-Cre (B) at different time points post-crush. Scale bar, 50 µm. (C) Quantification of p-S6+ RGCs. Data is presented as mean percentages of p-S6+and TUJ1+ cells among total TUJ1+ cells in the ganglion cell layer of each retina. Cell counts were performed on at least 4 non-consecutive sections for each animal, from four or five mice per group. *: p<0.01 by Dunnett’s test.
Figure 3
Figure 3. gp130 co-deletion abolishes axon regeneration effects of SOCS3 knockout
(A–C) Confocal images of optic nerves showing CTB-labeled axons around the lesion sites at 14 days post crush injury (dpc) from SOCS3f/f mice (A), gp130f/f mice (B), or SOCS3f/f and gp130f/f mice (C) injected with AAV-Cre. *: crush site. Scale bar: 100 µm. (D) Quantification of regenerating axons at different distances distal to the lesion sites at 14 days after crush injury. At least 5 different sections (every 4th section) from each animal were quantified. There were significant differences between the SOCS3f/f group and the other two groups (ANOVA with Bonferroni’s post-tes,t p < 0.05 for each distance, 8 animals used in each groups). (E–G) Fluorescent photomicrographs of retinal whole-mounts showing surviving TUJ1+ RGCs at 14 days after injury in AAV-Cre-injected SOCS3f/f (E), gp130f/f (F) or SOCS3f/f and gp130f/f (G) mice. Scale bar: 50 µm. (H) Quantification of RGC survival at 14 dpc expressed as a percentage of the total number of TUJ1+ RGCs in the contralateral (intact) retina (n = 8 for each group). For each retina, 15–20 fields were chosen from different parts of the retina. The total viable RGC number was obtained by multiplying the average number per field of TUJ1+ cells in the ganglion cell layer by the retinal area. There is a significant difference between the SOCS3f/f group and gp130f/f group, but not between SOCS3f/f group and SOCS3f/f/gp130f/f group (p < 0.05, ANOVA with post-hoc Tukey’s test).
Figure 4
Figure 4. Enhancement of axon regeneration in SOCS3-deleted mice by CNTF
(A–D) Confocal images of optic nerves showing CTB-labeled axons around the lesion ites at 14 days post crush injury (dpc) from SOCS3f/f mice with AAV-GFP (A, B) or AV-Cre (C, D) and subsequent injection of PBS (A, C) or CNTF (B, D). *: crush site. Scale bar: 100 µm. (E, F) Quantification of regenerating axons at different distances (250–1000 µm in E, and 1500–2500 µm in F) distal to the lesion sites at 14 days after crush injury. At least 5 different sections (every 4th section) from each animal were quantified. There were significant differences between the SOCS3f/f with CNTF group and the other three groups (ANOVA with Bonferroni’s post-test, p < 0.05 for each distance, 3 animals in each group).

Comment in

Similar articles

Cited by

References

    1. Betz UA, Bloch W, van den Broek M, Yoshida K, Taga T, Kishimoto T, Addicks K, Rajewsky K, Muller W. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med. 1998;188:1955–1965. - PMC - PubMed
    1. Cacalano NA, Sanden D, Johnston JA. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat Cell Biol. 2001;3:460–465. - PubMed
    1. Cafferty WB, Gardiner NJ, Gavazzi I, Powell J, McMahon SB, Heath JK, Munson J, Cohen J, Thompson SW. Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J Neurosci. 2001;21:7161–7170. - PMC - PubMed
    1. Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci. 2001;21:4731–4739. - PMC - PubMed
    1. Cao Z, Gao Y, Bryson JB, Hou J, Chaudhry N, Siddiq M, Martinez J, Spencer T, Carmel J, Hart RB, Filbin MT. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci. 2006;26:5565–5573. - PMC - PubMed

Publication types

MeSH terms